BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15788668)

  • 21. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
    Gertler R; Doll D; Maak M; Feith M; Rosenberg R
    Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced PPAR-gamma expression may correlate with the development of Barrett's esophagus and esophageal adenocarcinoma.
    Wang W; Wang R; Zhang Z; Li D; Yut Y
    Oncol Res; 2011; 19(3-4):141-7. PubMed ID: 21473290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New molecular concepts of Barrett's esophagus: clinical implications and biomarkers.
    Kyrgidis A; Kountouras J; Zavos C; Chatzopoulos D
    J Surg Res; 2005 May; 125(2):189-212. PubMed ID: 15854673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
    von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
    Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
    Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma.
    Keles M; Sahin I; Kurt A; Bozoglu C; Simsek G; Kabalar E; Tatar A
    Afr Health Sci; 2019 Mar; 19(1):1671-1676. PubMed ID: 31148997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical use of p53 in Barrett's esophagus.
    Keswani RN; Noffsinger A; Waxman I; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1243-9. PubMed ID: 16835318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
    Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
    Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of esophageal cancer.
    Metzger R; Schneider PM; Warnecke-Eberz U; Brabender J; Hölscher AH
    Onkologie; 2004 Apr; 27(2):200-6. PubMed ID: 15138356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma.
    Liu L; Chirala M; Younes M
    Anticancer Res; 2004; 24(5A):2919-24. PubMed ID: 15517897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma.
    Dunn JR; Risk JM; Langan JE; Marlee D; Ellis A; Campbell F; Watson AJ; Field JK
    Oncogene; 2003 Jun; 22(26):4134-42. PubMed ID: 12821948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients.
    Yakoub D; Keun HC; Goldin R; Hanna GB
    Cancer Res; 2010 Nov; 70(22):9129-36. PubMed ID: 20884633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression.
    Razvi MH; Peng D; Dar AA; Powell SM; Frierson HF; Moskaluk CA; Washington K; El-Rifai W
    Genes Chromosomes Cancer; 2007 Oct; 46(10):914-28. PubMed ID: 17636545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.